read with great interest the article by Do et al. on the clinical characteristics of older-onset versus common-age-of-onset gout [1]. The authors provide valuable insights into how age at onset influences comorbidities, treatment strategies, and disease expression. I would like to add a perspective on two important aspects that merit further discussion: the role of older women and the potential impact of hormonal therapy during menopause.
Mattioli, A.V. (2025). Menopause, Hormone Therapy, and Gout in Older Women: An Overlooked Connection : A Comment on "Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study" by Do et al. DRUGS & AGING, 42, 1201-1202 [10.1007/s40266-025-01262-w].
Menopause, Hormone Therapy, and Gout in Older Women: An Overlooked Connection : A Comment on "Comparison of Clinical Characteristics in Older-Onset and Common-Age-of-Onset Gout: A Prospective Gout Cohort Study" by Do et al
Mattioli, Anna Vittoria
Primo
Conceptualization
2025
Abstract
read with great interest the article by Do et al. on the clinical characteristics of older-onset versus common-age-of-onset gout [1]. The authors provide valuable insights into how age at onset influences comorbidities, treatment strategies, and disease expression. I would like to add a perspective on two important aspects that merit further discussion: the role of older women and the potential impact of hormonal therapy during menopause.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


